Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.


Journal

Respirology (Carlton, Vic.)
ISSN: 1440-1843
Titre abrégé: Respirology
Pays: Australia
ID NLM: 9616368

Informations de publication

Date de publication:
07 2022
Historique:
revised: 29 01 2022
received: 28 09 2021
accepted: 08 03 2022
pubmed: 24 3 2022
medline: 22 6 2022
entrez: 23 3 2022
Statut: ppublish

Résumé

Remodelling of pulmonary arteries (PA) contributes to the progression of pulmonary hypertension (PH). Periostin, a matricellular protein, has been reported to be involved in the development of PH. We examined the role of periostin in the pathogenesis of PH using different types of experimental PH. PH was induced by vascular endothelial growth factor receptor antagonist (Sugen5416) plus hypoxic exposure (SuHx) and venous injection of monocrotaline-pyrrole (MCT-P) in wild-type (WT) and periostin In PH induced by SuHx and MCT-P, PH and accumulation of M2 macrophage to small PA were attenuated in periostin Periostin is involved in the development of different types of experimental PH, and may also contribute to the pathogenesis of human PH.

Sections du résumé

BACKGROUND AND OBJECTIVE
Remodelling of pulmonary arteries (PA) contributes to the progression of pulmonary hypertension (PH). Periostin, a matricellular protein, has been reported to be involved in the development of PH. We examined the role of periostin in the pathogenesis of PH using different types of experimental PH.
METHODS
PH was induced by vascular endothelial growth factor receptor antagonist (Sugen5416) plus hypoxic exposure (SuHx) and venous injection of monocrotaline-pyrrole (MCT-P) in wild-type (WT) and periostin
RESULTS
In PH induced by SuHx and MCT-P, PH and accumulation of M2 macrophage to small PA were attenuated in periostin
CONCLUSION
Periostin is involved in the development of different types of experimental PH, and may also contribute to the pathogenesis of human PH.

Identifiants

pubmed: 35318760
doi: 10.1111/resp.14249
pmc: PMC9313806
doi:

Substances chimiques

Cell Adhesion Molecules 0
Postn protein, mouse 0
Vascular Endothelial Growth Factor A 0
Fibroblast Growth Factor 2 103107-01-3

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

529-538

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL148165
Pays : United States

Informations de copyright

© 2022 The Authors. Respirology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Respirology.

Références

J Appl Physiol (1985). 2007 Jan;102(1):390-8
pubmed: 17038494
Allergol Int. 2014;63(2):143-151
pubmed: 28942959
Atherosclerosis. 2010 Feb;208(2):358-65
pubmed: 19695571
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):60-8
pubmed: 26564821
Sci Immunol. 2016 Sep 16;1(3):eaaf9154
pubmed: 28783682
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545970
JCI Insight. 2021 Mar 22;6(6):
pubmed: 33591958
J Clin Invest. 2018 May 1;128(5):1956-1970
pubmed: 29629897
Am J Respir Cell Mol Biol. 2011 Aug;45(2):311-22
pubmed: 21037114
Allergol Int. 2017 Jul;66(3):404-410
pubmed: 28256388
Br J Dermatol. 2013 Apr;168(4):717-25
pubmed: 23110679
Transl Res. 2021 Jul;233:127-143
pubmed: 33691194
J Allergy Clin Immunol. 2013 Aug;132(2):305-12.e3
pubmed: 23791506
J Immunol Methods. 1980;33(3):239-47
pubmed: 6989919
J Vet Med Sci. 2017 Jun 29;79(6):1096-1102
pubmed: 28496027
J Appl Physiol (1985). 2004 Oct;97(4):1550-8; discussion 1549
pubmed: 15121739
Sci Transl Med. 2013 Aug 28;5(200):200ra117
pubmed: 23986401
J Allergy Clin Immunol. 2006 Jul;118(1):98-104
pubmed: 16815144
Eur Respir J. 2011 May;37(5):1119-27
pubmed: 21177844
J Clin Invest. 2012 Jul;122(7):2590-600
pubmed: 22684102
Circulation. 2010 Nov 16;122(20):2058-67
pubmed: 21041689
J Clin Invest. 2009 Mar;119(3):512-23
pubmed: 19197140
Circ Res. 2014 Jun 20;115(1):165-75
pubmed: 24951765
Cell Mol Life Sci. 2014 Apr;71(7):1279-88
pubmed: 24146092
Eur Respir J. 2019 Oct 10;54(4):
pubmed: 31320454
PLoS One. 2019 Aug 22;14(8):e0220795
pubmed: 31437169
PLoS One. 2017 Mar 29;12(3):e0174547
pubmed: 28355256
Respirology. 2022 Jul;27(7):529-538
pubmed: 35318760
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1171-82
pubmed: 21868504
PLoS One. 2019 Jul 24;14(7):e0214697
pubmed: 31339889
J Toxicol Sci. 2017;42(6):763-771
pubmed: 29142175
Am J Respir Crit Care Med. 2016 May 1;193(9):949-56
pubmed: 26756066
Front Immunol. 2021 Aug 27;12:722170
pubmed: 34512647
Int J Mol Sci. 2018 Sep 12;19(9):
pubmed: 30213070
Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2677-86
pubmed: 25941359
Circ Res. 2007 Aug 3;101(3):313-21
pubmed: 17569887
Cells. 2020 Oct 22;9(11):
pubmed: 33105588
Circ Res. 2020 Oct 9;127(9):1138-1152
pubmed: 32752980
Am J Respir Cell Mol Biol. 2012 May;46(5):677-86
pubmed: 22246863

Auteurs

Takashi Yoshida (T)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Tetsutaro Nagaoka (T)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Yuichi Nagata (Y)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Yoshifumi Suzuki (Y)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Takeo Tsutsumi (T)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Sachiko Kuriyama (S)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Junko Watanabe (J)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Shinsaku Togo (S)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Fumiyuki Takahashi (F)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Masakazu Matsushita (M)

Department of Internal Medicine and Rheumatology, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Yusuke Joki (Y)

Department of Cardiovascular Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Hakuoh Konishi (H)

Department of Cardiovascular Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Satoshi Nunomura (S)

Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.

Kenji Izuhara (K)

Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.

Simon J Conway (SJ)

Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Kazuhisa Takahashi (K)

Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH